GTS Securities’s Sabra Healthcare REIT SBRA Stock Holding History

GTS Securities’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,105	Closed	-$188K	–	1734
2025 Q3	$188K	Buy	+10,105	New	+$189K	0.01%	1310

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GTS Securities's SBRA Position: Q4 2025 in Review

GTS Securities sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 10,105 shares — an estimated $188K sold.

GTS Securities first reported a position in SBRA in Q3 2025 and held it in 1 quarter. The position peaked at $188K in Q3 2025. 441 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

GTS Securities reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
GTS Securities sold 10,105 Sabra Healthcare REIT shares in Q4 2025, an estimated $188K.
GTS Securities first reported a position in Sabra Healthcare REIT in Q3 2025 and held it in 1 quarter.
GTS Securities's Sabra Healthcare REIT position peaked at $188K in Q3 2025.
441 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.